|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Apoptosis/hydrolase
|
 |
|
Title:
|
 |
Crystal structure of the caspase-8/p35 complex
|
|
Structure:
|
 |
Early 35 kda protein. Chain: a. Synonym: p35, apoptosis-preventing protein. Engineered: yes. Caspase-8. Chain: b. Synonym: casp-8, ice-like apoptotic protease 5, mort1-assoc 3 homolog, mach, fadd-homologous ice/ced-3-like protease, f ice, flice, apoptotic cysteine protease, apoptotic protease
|
|
Source:
|
 |
Autographa californica nucleopolyhedro acmnpv. Organism_taxid: 46015. Gene: p35. Expressed in: escherichia coli. Expression_system_taxid: 562. Homo sapiens. Human. Organism_taxid: 9606.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.236
|
R-free:
|
0.296
|
|
|
Authors:
|
 |
G.Xu,M.Cirilli,Y.Huang,R.L.Rich,D.G.Myszka,H.Wu
|
Key ref:
|
 |
G.Xu
et al.
(2001).
Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex.
Nature,
410,
494-497.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Feb-01
|
Release date:
|
28-Mar-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
apoptosis
|
3 terms
|
 |
|
Biochemical function
|
protein binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
410:494-497
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex.
|
|
G.Xu,
M.Cirilli,
Y.Huang,
R.L.Rich,
D.G.Myszka,
H.Wu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Apoptosis is a highly regulated process that is crucial for normal development
and homeostasis of multicellular organisms. The p35 protein from baculoviruses
effectively prevents apoptosis by its broad-spectrum caspase inhibition. Here we
report the crystal structure of p35 in complex with human caspase-8 at 3.0 A
resolution, and biochemical and mutagenesis studies based on the structural
information. The structure reveals that the caspase is inhibited in the active
site through a covalent thioester linkage to p35, which we confirmed by gel
electrophoresis, hydroxylamine treatment and mass spectrometry experiments. The
p35 protein undergoes dramatic conformational changes on cleavage by the
caspase. The repositioning of the amino terminus of p35 into the active site of
the caspase eliminates solvent accessibility of the catalytic dyad. This may be
crucial for preventing hydrolysis of the thioester intermediate, which is
supported by the abrogation of inhibitory activity through mutations at the N
terminus of p35. The p35 protein also makes conserved contacts with the caspase
outside the active-site region, providing the molecular basis for the
broad-spectrum inhibitory activity of this protein. We demonstrate a new
molecular mechanism of caspase inhibition, as well as protease inhibition in
general.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1: Structure of the p35/caspase-8 complex. a, Ribbon
diagram of dimeric complex with the two-fold axis in the
vertical orientation. p35, cyan and green; -subunit
(p18) of caspase-8, magenta and red; -subunit
(p12) of caspase-8, orange and yellow. Ordered termini for p35-N
(residues 2 -87) and p35-C (residues 93 -299) are labelled. b,
Conformational transitions of p35 on cleavage. Residues with
differences in C positions
larger than 4.0 Å are shown in red, which include the N terminus
(residues 2 -12), the CD loop (residues 35 -40), the caspase
recognition sequence (residues 85 -87), the reactive-site loop
after the cleavage site (residues 93 -101), the FG loop
(residues 157 -165) and the KL loop (residues 254 -255). c,
Atomic model of the complex near the active site of caspase-8
overlaid with an omit electron density map (1.0 contour).
Potential hydrogen bonds are indicated by dotted lines. Side
chains for residue Met 86 of p35 and Tyr 412 of caspase-8 are
omitted for clarity.
|
 |
Figure 3.
Figure 3: Detailed interaction between p35 and caspase-8. a,
Interaction near the N terminus of p35 with the active site of
caspase-8. p35, cyan; -subunit
of caspase-8, magenta. b, Footprint of p35 on the surface of
caspase-8 (grey and yellow for each of the  -units).
Residues conserved among different caspases and main-chain atoms
are shown in blue, whereas those with significant variations are
shown in red. c, Interaction near the KL loop of p35. p35, cyan;
-subunit
of caspase-8, orange.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(2001,
410,
494-497)
copyright 2001.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Zhai,
E.Yu,
C.Jin,
K.Welsh,
C.W.Shiau,
L.Chen,
G.S.Salvesen,
R.Liddington,
and
J.C.Reed
(2010).
Vaccinia virus protein F1L is a caspase-9 inhibitor.
|
| |
J Biol Chem, 285,
5569-5580.
|
 |
|
|
|
|
 |
L.Galluzzi,
O.Kepp,
E.Morselli,
I.Vitale,
L.Senovilla,
M.Pinti,
L.Zitvogel,
and
G.Kroemer
(2010).
Viral strategies for the evasion of immunogenic cell death.
|
| |
J Intern Med, 267,
526-542.
|
 |
|
|
|
|
 |
T.Lin,
M.Yu,
W.Wu,
Q.Yu,
Q.Weng,
K.Yang,
M.Yuan,
and
Y.Pang
(2010).
Functional analysis of Spodoptera litura nucleopolyhedrovirus p49 gene during Autographa californica nucleopolyhedrovirus infection of SpLi-221 cells.
|
| |
Virus Genes, 41,
441-449.
|
 |
|
|
|
|
 |
A.Mazars,
A.Fernandez-Vidal,
O.Mondesert,
C.Lorenzo,
G.Prévost,
B.Ducommun,
B.Payrastre,
C.Racaud-Sultan,
and
S.Manenti
(2009).
A caspase-dependent cleavage of CDC25A generates an active fragment activating cyclin-dependent kinase 2 during apoptosis.
|
| |
Cell Death Differ, 16,
208-218.
|
 |
|
|
|
|
 |
J.W.Yu,
P.D.Jeffrey,
and
Y.Shi
(2009).
Mechanism of procaspase-8 activation by c-FLIPL.
|
| |
Proc Natl Acad Sci U S A, 106,
8169-8174.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Wang,
C.D.Blair,
K.E.Olson,
and
R.J.Clem
(2008).
Effects of inducing or inhibiting apoptosis on Sindbis virus replication in mosquito cells.
|
| |
J Gen Virol, 89,
2651-2661.
|
 |
|
|
|
|
 |
M.P.Guy,
and
P.D.Friesen
(2008).
Reactive-site cleavage residues confer target specificity to baculovirus P49, a dimeric member of the P35 family of caspase inhibitors.
|
| |
J Virol, 82,
7504-7514.
|
 |
|
|
|
|
 |
N.Agata,
R.Ahmad,
T.Kawano,
D.Raina,
S.Kharbanda,
and
D.Kufe
(2008).
MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.
|
| |
Cancer Res, 68,
6136-6144.
|
 |
|
|
|
|
 |
B.A.Callus,
and
D.L.Vaux
(2007).
Caspase inhibitors: viral, cellular and chemical.
|
| |
Cell Death Differ, 14,
73-78.
|
 |
|
|
|
|
 |
E.Lannan,
R.Vandergaast,
and
P.D.Friesen
(2007).
Baculovirus caspase inhibitors P49 and P35 block virus-induced apoptosis downstream of effector caspase DrICE activation in Drosophila melanogaster cells.
|
| |
J Virol, 81,
9319-9330.
|
 |
|
|
|
|
 |
J.C.Means,
T.Penabaz,
and
R.J.Clem
(2007).
Identification and functional characterization of AMVp33, a novel homolog of the baculovirus caspase inhibitor p35 found in Amsacta moorei entomopoxvirus.
|
| |
Virology, 358,
436-447.
|
 |
|
|
|
|
 |
J.C.Timmer,
and
G.S.Salvesen
(2007).
Caspase substrates.
|
| |
Cell Death Differ, 14,
66-72.
|
 |
|
|
|
|
 |
M.Chen,
L.Huang,
and
J.Wang
(2007).
Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity.
|
| |
Blood, 109,
4360-4367.
|
 |
|
|
|
|
 |
M.Chen,
L.Huang,
Z.Shabier,
and
J.Wang
(2007).
Regulation of the lifespan in dendritic cell subsets.
|
| |
Mol Immunol, 44,
2558-2565.
|
 |
|
|
|
|
 |
P.S.Ribeiro,
E.Kuranaga,
T.Tenev,
F.Leulier,
M.Miura,
and
P.Meier
(2007).
DIAP2 functions as a mechanism-based regulator of drICE that contributes to the caspase activity threshold in living cells.
|
| |
J Cell Biol, 179,
1467-1480.
|
 |
|
|
|
|
 |
R.Swanson,
M.P.Raghavendra,
W.Zhang,
C.Froelich,
P.G.Gettins,
and
S.T.Olson
(2007).
Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1.
|
| |
J Biol Chem, 282,
2305-2313.
|
 |
|
|
|
|
 |
H.R.Stennicke,
and
G.S.Salvesen
(2006).
Chemical ligation--an unusual paradigm in protease inhibition.
|
| |
Mol Cell, 21,
727-728.
|
 |
|
|
|
|
 |
I.Chowdhury,
B.Tharakan,
and
G.K.Bhat
(2006).
Current concepts in apoptosis: the physiological suicide program revisited.
|
| |
Cell Mol Biol Lett, 11,
506-525.
|
 |
|
|
|
|
 |
J.Dobó,
R.Swanson,
G.S.Salvesen,
S.T.Olson,
and
P.G.Gettins
(2006).
Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer.
|
| |
J Biol Chem, 281,
38781-38790.
|
 |
|
|
|
|
 |
M.Chen,
Y.H.Wang,
Y.Wang,
L.Huang,
H.Sandoval,
Y.J.Liu,
and
J.Wang
(2006).
Dendritic cell apoptosis in the maintenance of immune tolerance.
|
| |
Science, 311,
1160-1164.
|
 |
|
|
|
|
 |
S.Cathelin,
C.Rébé,
L.Haddaoui,
N.Simioni,
F.Verdier,
M.Fontenay,
S.Launay,
P.Mayeux,
and
E.Solary
(2006).
Identification of proteins cleaved downstream of caspase activation in monocytes undergoing macrophage differentiation.
|
| |
J Biol Chem, 281,
17779-17788.
|
 |
|
|
|
|
 |
F.Carlotti,
A.Zaldumbide,
P.Martin,
K.E.Boulukos,
R.C.Hoeben,
and
P.Pognonec
(2005).
Development of an inducible suicide gene system based on human caspase 8.
|
| |
Cancer Gene Ther, 12,
627-639.
|
 |
|
|
|
|
 |
F.L.Scott,
J.B.Denault,
S.J.Riedl,
H.Shin,
M.Renatus,
and
G.S.Salvesen
(2005).
XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.
|
| |
EMBO J, 24,
645-655.
|
 |
|
|
|
|
 |
I.N.Lavrik,
A.Golks,
and
P.H.Krammer
(2005).
Caspases: pharmacological manipulation of cell death.
|
| |
J Clin Invest, 115,
2665-2672.
|
 |
|
|
|
|
 |
J.Otlewski,
F.Jelen,
M.Zakrzewska,
and
A.Oleksy
(2005).
The many faces of protease-protein inhibitor interaction.
|
| |
EMBO J, 24,
1303-1310.
|
 |
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol, 21,
35-56.
|
 |
|
|
|
|
 |
S.Matza-Porges,
I.Horresh,
E.Tavor,
A.Panet,
and
A.Honigman
(2005).
Expression of an anti apoptotic recombinant short peptide in mammalian cells.
|
| |
Apoptosis, 10,
987-996.
|
 |
|
|
|
|
 |
A.D.Schimmer,
K.Welsh,
C.Pinilla,
Z.Wang,
M.Krajewska,
M.J.Bonneau,
I.M.Pedersen,
S.Kitada,
F.L.Scott,
B.Bailly-Maitre,
G.Glinsky,
D.Scudiero,
E.Sausville,
G.Salvesen,
A.Nefzi,
J.M.Ostresh,
R.A.Houghten,
and
J.C.Reed
(2004).
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.
|
| |
Cancer Cell, 5,
25-35.
|
 |
|
|
|
|
 |
C.M.Forsyth,
D.Lemongello,
D.J.LaCount,
P.D.Friesen,
and
A.J.Fisher
(2004).
Crystal structure of an invertebrate caspase.
|
| |
J Biol Chem, 279,
7001-7008.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Gerstein,
and
N.Echols
(2004).
Exploring the range of protein flexibility, from a structural proteomics perspective.
|
| |
Curr Opin Chem Biol, 8,
14-19.
|
 |
|
|
|
|
 |
M.Holcík
(2004).
Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.
|
| |
Expert Opin Ther Targets, 8,
241-253.
|
 |
|
|
|
|
 |
S.J.Riedl,
and
Y.Shi
(2004).
Molecular mechanisms of caspase regulation during apoptosis.
|
| |
Nat Rev Mol Cell Biol, 5,
897-907.
|
 |
|
|
|
|
 |
C.Z.Ni,
C.Li,
J.C.Wu,
A.P.Spada,
and
K.R.Ely
(2003).
Conformational restrictions in the active site of unliganded human caspase-3.
|
| |
J Mol Recognit, 16,
121-124.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Xu,
R.L.Rich,
C.Steegborn,
T.Min,
Y.Huang,
D.G.Myszka,
and
H.Wu
(2003).
Mutational analyses of the p35-caspase interaction. A bowstring kinetic model of caspase inhibition by p35.
|
| |
J Biol Chem, 278,
5455-5461.
|
 |
|
|
|
|
 |
M.Sulpizi,
A.Laio,
J.VandeVondele,
A.Cattaneo,
U.Rothlisberger,
and
P.Carloni
(2003).
Reaction mechanism of caspases: insights from QM/MM Car-Parrinello simulations.
|
| |
Proteins, 52,
212-224.
|
 |
|
|
|
|
 |
M.Sulpizi,
U.Rothlisberger,
and
P.Carloni
(2003).
Molecular dynamics studies of caspase-3.
|
| |
Biophys J, 84,
2207-2215.
|
 |
|
|
|
|
 |
O.del Pozo,
and
E.Lam
(2003).
Expression of the baculovirus p35 protein in tobacco affects cell death progression and compromises N gene-mediated disease resistance response to Tobacco mosaic virus.
|
| |
Mol Plant Microbe Interact, 16,
485-494.
|
 |
|
|
|
|
 |
R.Filipek,
M.Rzychon,
A.Oleksy,
M.Gruca,
A.Dubin,
J.Potempa,
and
M.Bochtler
(2003).
The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease.
|
| |
J Biol Chem, 278,
40959-40966.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.E.Clarke,
and
R.J.Clem
(2003).
Insect defenses against virus infection: the role of apoptosis.
|
| |
Int Rev Immunol, 22,
401-424.
|
 |
|
|
|
|
 |
C.D.Bortner,
and
J.A.Cidlowski
(2002).
Cellular mechanisms for the repression of apoptosis.
|
| |
Annu Rev Pharmacol Toxicol, 42,
259-281.
|
 |
|
|
|
|
 |
H.R.Stennicke,
C.A.Ryan,
and
G.S.Salvesen
(2002).
Reprieval from execution: the molecular basis of caspase inhibition.
|
| |
Trends Biochem Sci, 27,
94.
|
 |
|
|
|
|
 |
M.J.Eddins,
D.Lemongello,
P.D.Friesen,
and
A.J.Fisher
(2002).
Crystallization and low-resolution structure of an effector-caspase/P35 complex: similarities and differences to an initiator-caspase/P35 complex.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
299-302.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2002).
Survey of the year 2001 commercial optical biosensor literature.
|
| |
J Mol Recognit, 15,
352-376.
|
 |
|
|
|
|
 |
S.J.Zoog,
J.J.Schiller,
J.A.Wetter,
N.Chejanovsky,
and
P.D.Friesen
(2002).
Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo.
|
| |
EMBO J, 21,
5130-5140.
|
 |
|
|
|
|
 |
Y.Shi
(2002).
Mechanisms of caspase activation and inhibition during apoptosis.
|
| |
Mol Cell, 9,
459-470.
|
 |
|
|
|
|
 |
Z.Pei,
G.Reske,
Q.Huang,
B.D.Hammock,
Y.Qi,
and
N.Chejanovsky
(2002).
Characterization of the apoptosis suppressor protein P49 from the Spodoptera littoralis nucleopolyhedrovirus.
|
| |
J Biol Chem, 277,
48677-48684.
|
 |
|
|
|
|
 |
F.Li,
D.Zhang,
and
K.Fujise
(2001).
Characterization of fortilin, a novel antiapoptotic protein.
|
| |
J Biol Chem, 276,
47542-47549.
|
 |
|
|
|
|
 |
L.Goyal
(2001).
Cell death inhibition: keeping caspases in check.
|
| |
Cell, 104,
805-808.
|
 |
|
|
|
|
 |
S.Ye,
A.L.Cech,
R.Belmares,
R.C.Bergstrom,
Y.Tong,
D.R.Corey,
M.R.Kanost,
and
E.J.Goldsmith
(2001).
The structure of a Michaelis serpin-protease complex.
|
| |
Nat Struct Biol, 8,
979-983.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Suzuki,
Y.Nakabayashi,
and
R.Takahashi
(2001).
Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death.
|
| |
Proc Natl Acad Sci U S A, 98,
8662-8667.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|